![initial d street stage lba initial d street stage lba](https://i.ytimg.com/vi/nmGOvQS04_U/maxresdefault.jpg)
These numbers likely include the studies listed in this appendix.ġ Open trials listed on as of December 4, 2015. A similar search done under the subtopic of ovarian cancer in general revealed 385 open studies and 223 studies that are closed and active but not recruiting. Furthermore, the committee acknowledges that by limiting the list to studies that specifically target epithelial ovarian cancers, the many more studies being performed on ovarian cancers in general are excluded. The committee also acknowledges that many of these studies are not limited to ovarian cancers. This appendix is not intended to serve as an exhaustive list of all studies currently under way in ovarian cancer. The purpose of this appendix is to give a broader sense of the types of studies that are under way as well as to give a sense of the priority areas of focus. The table lists the types of interventions used in each study, but does not include placebos (where used), nor the different types of administration of the same intervention (e.g., different dosage amounts of the same drug). The studies are presented in the following table by study phase and by study type (interventional versus observational). This search resulted in 204 interventional studies and 31 observational studies. The data in this table were generated by a search performed on on December 4, 2015, using the subtopic of “epithelial ovarian cancer.” Studies with an “unknown” status have been excluded.
![initial d street stage lba initial d street stage lba](https://d-lab.mit.edu/sites/default/files/2021-04/Climate-Clock-2_0.jpg)
This appendix includes a listing of the clinical trials in epithelial ovarian cancer that are open and recruiting, open and not yet recruiting (denoted by an asterisk), or active but closed to recruiting as of the writing of this report.
![initial d street stage lba initial d street stage lba](https://i.ytimg.com/vi/kSITpbfhYJY/maxresdefault.jpg)
Open and Active Clinical Trials on Epithelial Ovarian Cancer 1